Wednesday, October 31, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Astex Pharmaceuticals in drug discovery pact with Cancer Research Technology ...
domain-B
Astex Pharmaceuticals, Inc, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, Cancer Research Technology Limited (CRT) and Newcastle University have signed a major five-year strategic drug ...
See all stories on this topic »
Switzerland's Lonza axes 500 jobs to cut costs
Reuters India
The cuts at the Basel-based firm, which makes pharmaceutical ingredients for drugmakers such as GlaxoSmithKline and Abbott, equate to around 5 percent of its global workforce of about 11,000. In its third-quarter business update on Wednesday, Lonza ...
See all stories on this topic »
Catalyst Pharmaceutical Partners and BioMarin Pharmaceutical Enter Into ...
NASDAQ
CORAL GABLES, Fla., Oct. 31, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) and BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that they have entered into a strategic collaboration for the rights to ...
See all stories on this topic »
Patheon enters pact with Vion to acquire specialty pharma co, Banner Pharmacaps
pharmabiz.com
Patheon Inc. a leading provider of contract development and manufacturing services to the global pharmaceutical industry, has entered into a definitive agreement with Netherlands-based foodstuffs and ingredients manufacturer, Vion N.V., to acquire ...
See all stories on this topic »
DGAP-News: Astex Pharmaceuticals to Present at EORTC-NCI-AACR
Equities.com
DGAP Astex Pharmaceuticals, Inc. 31.10.2012 11:00 --------------------------------------------------------------------------- DUBLIN, Calif., 2012-10-31 11:00 CET (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company ...
See all stories on this topic »
Novartis to start construction of new biotechnology facility in Singapore with ...
Reuters
Investment supports growing pipeline of biologics portfolio representing 25% of current clinical pharmaceutical research pipeline; Singapore will operate as a technological competence center for biotechnology and pharmaceutical production; Construction ...
See all stories on this topic »
Global High Potency Active Pharmaceutical Ingredients (HPAPIs) Market is ...
Sacramento Bee
India and China will be the major countries to register high growth rate in the high potency active pharmaceutical ingredients (HPAPIs) market due to rising health awareness, growing economies and improving healthcare systems. Browse the full report at ...
See all stories on this topic »
Administering two new pharmaceutical drugs to combat hepatitis C increases ...
Basque Research
Administering two new pharmaceutical drugs - Telaprevir and Boceprevir -, together with those currently used to date - interferon and ribavirine -, enables increasing the cure rate of hepatitis C patients from 45% to 75% on average, according to Doctor ...
See all stories on this topic »
May not see 35% growth in H1 sustaining in H2
Moneycontrol.com
We are growing in excess of 15 percent ahead of the overall Indian pharmaceutical industry. This is all on account of a restructuring exercise that we did last year where we increased the field force, we restructured the product mix. We increased the ...
See all stories on this topic »
TAKEDA PHARMACEUTICAL COMPANY LIMITED : Millennium and Takeda ...
4-traders
Millennium: The Takeda Oncology Company and Takeda Pharmaceutical Company Limited (TSE:4502, "Takeda"), today announced that the European Commission (EC) has granted conditional marketing authorization for ADCETRIS® (brentuximab vedotin) ...
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Tuesday, October 30, 2012

Google Alert - pharmaceutical news

News7 new results for pharmaceutical news
 
Fosun Pharmaceutical Shares Fall 8% on Hong Kong Debut
Wall Street Journal
HONG KONG—Drug maker Shanghai Fosun Pharmaceutical (Group) Co., which raised $512 million in the first major initial public offering in Hong Kong in months, saw its shares fall 8% on their debut Tuesday, signaling that demand for new share sales has ...
See all stories on this topic »
Glenmark Q2 net up nearly three fold at Rs 156.75 cr
Zee News
New Delhi: Glenmark Pharmaceuticals on Tuesday said its consolidated net profit rose by nearly three fold to Rs 156.75 crore for the quarter ended September 30, 2012, mainly on account of robust sales across all segments. The company had posted a net ...
See all stories on this topic »

Zee News
Valeant Pharmaceuticals Reschedules Its Third Quarter 2012 Financial Results ...
Sacramento Bee
MONTREAL, Oct. 30, 2012 -- /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it has decided to reschedule its webcast and conference call to discuss financial results for the 2012 third quarter ...
See all stories on this topic »
Ohio to Get $1.4M in Pharmaceutical Settlement
Pharmaceutical Processing
The U.S. Justice Department said Thursday that Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle allegations that the company promoted three drugs for uses that were not medically accepted. The Justice Department says the three ...
See all stories on this topic »
Watson Pharma sells Rugby OTC product trademark & assets for $117 mn to ...
pharmabiz.com
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, has sold its Rugby over-the-counter (OTC) pharmaceutical products and trademarks to The Harvard Drug Group, LLC, a leading distributor and provider of private label OTCs and ...
See all stories on this topic »
Cardinal Health quarterly profits rise, reaffirms outlook
Reuters
Revenue dipped 3 percent to $25.9 billion in the quarter, with revenue from its pharmaceutical segment declining 4 percent to $23.5 billion and revenue from its medical segment rising 1 percent to $2.4 billion. Cardinal blamed slow growth in its ...
See all stories on this topic »
Astex Pharmaceuticals gives £5m boost to Newcastle University
nebusiness.co.uk
Newcastle University has cemented its reputation as a world leader in the fight against the illness as it has signed a £5m partnership with an international pharmaceutical company to develop new cancer drugs. Astex Pharmaceuticals – a global leader in ...
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Monday, October 29, 2012

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news
 
Par Pharmaceutical Acquires Rights to Market and Distribute Generic Seroquel ...
Sacramento Bee
WOODCLIFF LAKE, N.J., Oct. 29, 2012 -- /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its Par Pharmaceutical, Inc. operating subsidiary has entered into an exclusive acquisition and license agreement with Handa ...
See all stories on this topic »
Del Mar Pharmaceuticals Expands Collaboration with Guangxi Wuzhou ...
Sacramento Bee
VANCOUVER, Oct. 29, 2012 -- /PRNewswire/ -- Del Mar Pharmaceuticals (BC) Ltd. ("DelMar") today announced a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company, a subsidiary of publicly traded Guangxi Wuzhou Zhongheng Group Co.
See all stories on this topic »
Shanghai Pharmaceuticals Announces 2012 Third Quarterly Report
iStockAnalyst
HONG KONG, Oct. 29, 2012 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co. Ltd., ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 02607.HK), today announced its third quarterly ...
See all stories on this topic »
Connecticut joins agreement with pharmaceutical company
Connectcut Plus
Attorney General George Jepsen said that Connecticut has joined with other states and the federal government to settle allegations that Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), paid kickbacks and engaged in off-label marketing campaigns that ...
See all stories on this topic »
Pharmaceuticals Procured Through Tender, Concessionaires - Liow
Bernama
KUALA LUMPUR, Oct 29 (Bernama) -- The Health ministry procure pharmaceutical supplies through tender, quotation, direct purchase and through concession companies before being distributed to the ministry's facilities nationwide, its minister Datuk Seri ...
See all stories on this topic »
ECI Pharmaceuticals adding 20 jobs in Fort Lauderdale
Bizjournals.com
The Greater Fort Lauderdale Alliance and Enterprise Florida announced that the pharmaceutical company would invest $1 million into the expansion of both its research and development and its analytical testing laboratories. The 20 new jobs, to be ...
See all stories on this topic »
Watson Pharma sells Rugby over-the-counter pharmaceutical products ...
RTT News
Watson Pharmaceuticals, Inc. (WPI: Quote), a specialty pharmaceutical company, announced it has sold its Rugby over-the-counter pharmaceutical products and trademarks to The Harvard Drug Group, LLC, a distributor and provider of private label OTCs ...
See all stories on this topic »
Sucampo Pharmaceuticals Inc. A Stock Upgraded (SCMP)
TheStreet.com
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk ...
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Sunday, October 28, 2012

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news
 
Sun Pharmaceutical awaits USFDA approval for cancer drug Lipodox
Economic Times
NEW DELHI: After gaining market access under a contingency plan by the USFDA, drug major Sun Pharmaceutical Industries is awaiting approval from the health regulator for its cancer drug Lipodox. The company's temporary supply of the drug to the US is ...
See all stories on this topic »
2012's Best Pharmaceutical Stock
DailyFinance
Big Pharma stocks have rewarded shareholders handsomely in 2012, with shares of many of the top names in the industry up 20% or 30% year to date. While there are plenty of good choices among pharmaceuticals to pick from, perhaps no major player has ...
See all stories on this topic »
Trial brings cannabis spray closer to pharmacies
Sydney Morning Herald
A spokeswoman for Novartis, the company employed by GW Pharmaceuticals to commercialise the drug in Australia, said it was working with the Therapeutic Goods Administration to make Sativex available to patients with multiple sclerosis who suffer from ...
See all stories on this topic »
Medical Representative for a Confedintial Pharmaceutical Company
Emirates 24/7
Medical Representatives are the front line for the pharmaceutical company, who promote for its brand/product, convince doctors about the product, check the pharmacy feedback, catching orders, checking availability and shelf quantity, reporting ...
See all stories on this topic »
Pharmaceutical drug abuse: a social dilemma
The Island.lk (subscription)
Pharmaceutical drug abuse has become popular among recreational drugs users in South Asia as revealed by the United Nations Office on Drugs and Crime, 2011. The recent deaths caused by the abuse of 'prescription-only' drugs as stipulated by Schedule ...
See all stories on this topic »

The Island.lk (subscription)
Drug Shortage, Aging Baby Boomers Create A Great Opportunity For Teva
Seeking Alpha
If this problem intensifies, nobody wins other than the pharmaceutical manufacturers that have the ability to quickly increase supply at a low cost. Another important trend for investors to pay attention is the massive aging of baby boomers: "The ...
See all stories on this topic »
MBI business incubator boasts a high success rate
Worcester Telegram
Li Ying Yan, president of EpigenDX, said the company is a contract researcher for the pharmaceutical industry, working with companies, government agencies and epidemic labs. The company is also involved in research and development for cancer ...
See all stories on this topic »
Investors Neglect Solazyme's Leadership In Industrial Biotechnology
Seeking Alpha
In many ways, the company is more accurately similar to companies within the sphere of pharmaceutical drugs. Instead of finding a cure to pancreatic cancer, for instance, the company is providing a solution to the unmet need for an enhanced ...
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Saturday, October 27, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
Pharmaceutical regulatory failure must be remedied
Longmont Daily Times-Call
While investigations are ongoing in the fungal meningitis outbreak that has sickened more than 300 Americans and killed 24, it's clear that the regulatory system that oversees pharmaceutical compounding failed and needs to be strengthened. The steroid ...
See all stories on this topic »
Pharmaceutical company Boehringer Ingelheim to pay $95 million settlement
Milwaukee Journal Sentinel (blog)
State and federal governments will be receiving a $95 million boost from a pharmaceutical company accused of improperly marketing four drugs and paying doctors kickbacks as an incentive to prescribe the drugs. The money comes from a settlement that ...
See all stories on this topic »
Israeli pharmaceutical giant Teva gets FDA approval for leukemia drug
Haaretz
Israeli pharmaceutical giant Teva gets FDA approval for leukemia drug. Synribo, also known as omacetaxine mepesuccinate, treats a type of chronic myelogenous leukemia in patients whose cancer has progressed after treatment with at least two drugs from ...
See all stories on this topic »

Haaretz
5 Pharmaceutical Stocks to Sell Now
Investorplace.com
The ratings of five Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). This week, Flamel Technologies (NASDAQ:FLML) falls to a D ("sell"), worse than ...
See all stories on this topic »
Fla. pharmaceutical company shut down
WKMG Orlando
The Florida Department of Health (DOH) Friday, issued an Emergency Suspension Order (ESO) against Rejuvi Pharmaceuticals, Inc. The order shuts down the Boca Raton business from operating as a community drug compounding pharmacy in the state of ...
See all stories on this topic »
Telenor signs up with Sun Pharma's Valia
Hindu Business Line
Telenor Group will sell 26 per cent stake in its new Indian venture to Sun Pharmaceutical's Executive Director Sudhir Valia. The new entity, Telewings Communications Pvt Ltd, has signed a partnership agreement with Lakshdeep Investments & Finance Pvt ...
See all stories on this topic »

Hindu Business Line
Watson Receives FDA Approval for Generic Actos; Forest Labs in Settlement Pact
Equities.com
Watson Pharmaceuticals, Inc. (NYSE: WPI) announced Watson has launched a generic version of Actos® (Pioglitazone Hydrochloride 15mg, 30mg and 45mg tablets) after receiving final approval today from the U.S. FDA. Watson began shipping the product ...
See all stories on this topic »
CIPMMA adopts resolution opposing DCGI's order seeking to stop brand based ...
pharmabiz.com
The executive committee of the Consortium of Indian Pharmaceutical Manufacturers & Marketers Association (CIPMMA), an association of manufacturers of branded pharmaceutical products, has strongly condemned the DCGI's order saying that the ...
See all stories on this topic »
Valeant Pharmaceuticals Price Target Lowered to $67.00 at Paradigm Capital ...
Zolmax
Valeant Pharmaceuticals logo Valeant Pharmaceuticals (NYSE: VRX) had its price target lowered by Paradigm Capital to $67.00 in a research report sent to investors on Wednesday morning. "We continue to hold a positive view toward Valeant's unique ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Friday, October 26, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Pharmaceutical company to pay $95M to settle allegations of improper drug ...
Washington Post
WASHINGTON — Boehringer Ingelheim Pharmaceuticals Inc. will pay $95 million to settle allegations that the company promoted three drugs for uses that were not medically accepted, the government announced Thursday. The Justice Department said the ...
See all stories on this topic »
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Teva Receives Approval For ...
4-traders
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) approved SYNRIBO (omacetaxine mepesuccinate) for Injection to treat adult patients with chronic phase (CP) or accelerated phase (AP) ...
See all stories on this topic »
Pharmaceutical industry neglects developing countries
Deutsche Welle
A billion people across the world do not receive adequate medical attention. In developing countries, cholera and tuberculosis - diseases that long ago lost their horror in the West - still often mean certain death. According to the World Health ...
See all stories on this topic »

Deutsche Welle
SAP ERP Project Manager - Pharmaceutical Company - London
The Independent
This pharmaceutical organisation is embarking on an ambitious transformational programme of work to implement a new SAP ERP system across the business. This Pharmaceutical Company are looking to achieve a challenging target that will require them to ...
See all stories on this topic »
5 Pharmaceutical Stocks to Buy Now
Investorplace.com
This week, five Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). Johnson & Johnson (NYSE:JNJ) is making progress this week as its rating of C ...
See all stories on this topic »
Sun Pharma MD's brother-in-law to buy stake in Telenor
Business Standard
Promoters of Indian pharmaceutical companies are busy with diversifying their businesses into new areas. After Ajay Piramal's investment into Vodafone India, another pharmaceuticals veteran - Sudhir Valia, promoter of Sun Pharmaceuticals and ...
See all stories on this topic »
Overcharging set to cost pharma companies full sales revenue of drug
Economic Times
... entire sale amount from the date of introduction of the product till issue of the price notification order shall be recovered from the company, treating the entire sale proceeds as 'unauthorised sales'," the National Pharmaceutical Pricing ...
See all stories on this topic »
BioMarin Pharmaceutical Management Discusses Q3 2012 Results - Earnings ...
Seeking Alpha
This nonconfidential presentation contains forward-looking statements about the business prospects of BioMarin Pharmaceutical, including expectations regarding BioMarin's financial performance, commercial products and potential future products in ...
See all stories on this topic »
TORRENT PHARMACEUTICALS LIMITED : Torrent Pharma records 13% growth ...
4-traders
Ahmedabad-based Torrent Pharmaceuticals Limited, today released its financial results for the quarter ended 30th September, 2012. The Q2' 12-13 revenues stood at Rs. 777 crores, up by 13% from Rs. 685 crores in the comparable quarter of last year.
See all stories on this topic »
BioMed Realty Announces 80500 Square Foot Lease Expansion For Regeneron ...
Sacramento Bee
BioMed Realty delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in ...
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Thursday, October 25, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Par Pharmaceutical Receives Final Approval To Market Tretinoin Capsules
The Herald | HeraldOnline.com
WOODCLIFF LAKE, N.J., Oct. 25, 2012 — /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that its operating subsidiary, Anchen Pharmaceuticals, Inc., has received final approval from the U.S. Food and Drug Administration for its ...
See all stories on this topic »
KV Pharmaceutical, Apple, Huawei: Intellectual Property
Businessweek
K-V Pharmaceutical Co. (KVPHQ), the drugmaker that blamed lax federal enforcement for its bankruptcy this year, filed a U.S. trade complaint accusing more than 40 compounding pharmacies of infringing its property rights. New England Compounding ...
See all stories on this topic »
Desitin Pharmaceuticals Selects Cloud-Based Veeva CRM to Support ...
Sacramento Bee
When German-based pharmaceutical company, Desitin, expanded into the United Kingdom, it searched for a Customer Relationship Management (CRM) system that could grow with its new sales force. After a thorough review of leading CRM systems, the ...
See all stories on this topic »
Glaxo Judgment In Canada: Relevance For India
Moneycontrol.com
Glaxo Canada, a subsidiary of the leading pharmaceutical company ('Glaxo UK') was involved in the purchase of ranitidine, a key raw ingredient, or in more accurate terms: Active Pharmaceutical Ingredient ('API') from its related Swiss company Adechsa S ...
See all stories on this topic »

Moneycontrol.com
Synergy Pharmaceutical Could Almost Double In Value With Plecanatide
Seeking Alpha
When an investor looks for a catalyst in the pharma industry to increase the value of a company's stock, it is usually a new drug. Synergy Pharmaceuticals (SGYP) may be one of these companies with its drug-- Placanatide. Considering the drug's lack of ...
See all stories on this topic »
Shire chief to step down
Financial Times
He will be replaced by Flemming Ornskov, who joins Shire from his previous role as chief marketing officer at Bayer, the German pharmaceutical group. "It's the right time to move on. I got married last year and want to spend more time with my family ...
See all stories on this topic »
People on the move: outsourcing jobs
OutSourcing-Pharma.com
In a news release, the firm said: "A physician by training, and with twenty years' experience in the pharmaceutical industry, Schnorr brings extensive expertise across the whole drug development spectrum to Quintiles." AMRI has named Steven Hagen its ...
See all stories on this topic »

OutSourcing-Pharma.com
API 'up' despite sales decline
Sydney Morning Herald
DRUG wholesaler and pharmacy retailer Australian Pharmaceutical Industries has swung to a full-year profit and declared its outlook ''promising'', despite tipping another year of declining earnings. API, one of Australia's three pharmaceutical ...
See all stories on this topic »

Sydney Morning Herald
OASMIA PHARMACEUTICAL AB : Prospectus regarding Oasmia ...
4-traders
The Board of Directors of Oasmia Pharmaceutical AB (publ) ("Oasmia") has prepared a prospectus for the purpose of the rights issue, which was announced on October 18, 2012. The prospectus has today been approved by and registered with the Swedish ...
See all stories on this topic »
Lupin gets USFDA nod for generic contraceptive tablets
Firstpost
The company's subsidiary, Lupin Pharmaceuticals Inc, has received final approval from the United States Food and Drugs Administration (USFDA) to market these tablets in the strength of 0.15 mg/0.03 mg, it added. The tablets are generic version of Teva ...
See all stories on this topic »

Firstpost


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost